| Literature DB >> 31849453 |
Ali Nemati1, Reza Alipanah-Moghadam1, Leila Molazadeh1, Abbas Naghizadeh Baghi2.
Abstract
BACKGROUND: Glutamine is the most abundant amino acid in plasma and skeletal muscles and an important fuel for immune system cells. It has beneficial anti-inflammatory and antioxidant properties which may be considered as a potentially useful supplement for athletes. The present study was conducted to investigate the effect of glutamine supplementation on oxidative stress and matrix metalloproteinase 2 and 9 after exhaustive exercise in young healthy males.Entities:
Keywords: MMP2&9; exhaustive exercise; glutamine; oxidative stress
Mesh:
Substances:
Year: 2019 PMID: 31849453 PMCID: PMC6912001 DOI: 10.2147/DDDT.S218606
Source DB: PubMed Journal: Drug Des Devel Ther ISSN: 1177-8881 Impact factor: 4.162
The Slope and Speed of Treadmill During Exhaustive Exercise
| Steps | Time (min) | Speed (km/h) | Slope (%) |
|---|---|---|---|
| 1 | 0 | 2.74 | 10% |
| 2 | 3 | 4.02 | 12% |
| 3 | 6 | 5.47 | 14% |
| 4 | 9 | 6.76 | 16% |
| 5 | 12 | 8.05 | 18% |
| 6 | 15 | 8.85 | 20% |
| 7 | 18 | 9.65 | 22% |
The Comparison of Anthropometric Factors and Nutritional Intake in Control and Supplement Groups
| Variables | Groups | P value | Variables | Groups | P value | ||
|---|---|---|---|---|---|---|---|
| Supplement M±SD | Control M±SD | Supplement M±SD | Control M±SD | ||||
| Weight (kg) | 72.32 ± 12.6 | 79.27 ± 13.58 | 0.16 | V. B1 (mg) | 1.5 ± 0.21 | 1.55 ± 0.38 | 0.65 |
| BMI (kg/m2) | 22.06 ± 3.68 | 24.15 ± 3.92 | 0.14 | V. B2 (mg) | 1.33 ± 0.27 | 1.39 ± 0.35 | 0.62 |
| Height (cm) | 181.06 ± 4.31 | 180.66 ± 2.16 | 0.8 | V. B3 (mg) | 24.43 ± 8.11 | 23.75 ± 3.81 | 0.77 |
| Cal (Kcal/day) | 2463.5 ± 255.5 | 2553 ± 386.7 | 0.46 | V. B6 (mg) | 1.35 ± 0.46 | 1.1 ± 0.29 | 0.06 |
| Protein (g) | 95.6 ± 13.1 | 95.33 ± 13.3 | 0.96 | V. B9 (µg) | 121.2 ± 70.2 | 118.5 ± 47.7 | 0.9 |
| CHO (g) | 327.3 ± 32.2 | 346.3 ± 70.5 | 0.35 | V. C (mg) | 51 ± 35.28 | 56.7 ± 24.7 | 0.61 |
| Total fat (g) | 85.2 ± 12.1 | 87.4 ± 15.2 | 0.66 | Ca (mg) | 609.07 ± 221.74 | 634.53 ± 273.6 | 0.78 |
| SF (g) | 16.13 ± 2.9 | 19.13 ± 5.8 | 0.09 | Fe (mg) | 20.8 ± 5.47 | 24.2 ± 7.26 | 0.16 |
| PUFA (g) | 13.4 ± 4.7 | 13.6 ± 4.1 | 0.9 | Zn (mg) | 4.19 ± 1.04 | 3.41 ± 1.14 | 0.06 |
| MUFA (g) | 20.2 ± 3.4 | 22.9 ± 5.5 | 0.12 | Cu (mg) | 0.93 ± 0.26 | 0.86 ± 0.14 | 0.36 |
| Glutamic Acid (g) | 3.9 ± 1.7 | 3.3 ± 1.7 | 0.39 | Mg (mg) | 153.7 ± 58.38 | 143.2 ± 34.52 | 0.56 |
| Glucose (g) | 4.2 ± 3.9 | 3.1 ± 2.8 | 0.32 | K (mg) | 2013.8 ± 650. 3 | 1835.4 ± 282.9 | 0.34 |
| Fructose (g) | 4.3 ± 3.9 | 3.6 ± 3.1 | 0.39 | Biotin (mg) | 10.9 ± 10.4 | 10.25 ± 9.65 | 0.97 |
| V. E (mg) | 14 ± 3.1 | 15.4 ± 2.9 | 0.21 | V. B12 (µg) | 3.8 ± 1.29 | 4.25 ± 1.4 | 0.37 |
| V.D (µg) | 1.26 ± 0.93 | 1.5 ± 1.27 | 0.25 | V.K (µg) | 40.24 ± 26.8 | 52.33 ± 49.7 | 0.41 |
Abbreviations: CHO, carbohydrate; BMI, Body Mass Index; V, Vitamine; V.B9, Folic acid; Ca, Calcium; Mg, Magnesium; Cal, Calorie; MUFA, Mono unsaturated fat (g); PUFA, Poly unsaturated fat; SF, Saturated fat; K, Potassium; P, Phosphorous; Se, Selenium; Fe, Iron; Cu, Copper; Zn, Zinc.
The Comparison of Matrix Metalloproteinase, Inflammatory and Oxidant Parameters Before and After 2 Weeks Glutamine Supplementation in Both Groups
| Variables | Measurement Stage | Supplement Group | Control Group | P value |
|---|---|---|---|---|
| MMP2 (ng/mL) | Before the intervention | 38.92 ± 6.4 | 35.18 ± 8.35 | 0.18 |
| Two weeks after the intervention | 35.46 ± 7.79 | 32.6 ±6.76 | 0.29 | |
| P value | 0.06 | 0.2 | ||
| MMP9 (ng/mL) | Before the intervention | 924.55 ± 362.58 | 804.6 ± 379.45 | 0.38 |
| Two weeks after the intervention | 981.85 ± 288.11 | 988.36 ± 417.34 | 0.96 | |
| P value | 0.5 | 0.3 | ||
| TAC (mmol/l) | Before the intervention | 0.21 ± 0.02 | 0.22 ± 0.02 | 0.69 |
| Two weeks after the intervention | 0.23 ± 0.02 | 0.22 ± 0.02 | 0.83 | |
| P value | 0.03* | 0.2 | ||
| hs-CRP (mg/l) | Before the intervention | 1.1 ± 0.94 | 1. 26 ± 0.89 | 0.65 |
| Two weeks after the intervention | 1.1 ± 0.71 | 1.92 ± 1.83 | 0.03● | |
| P value | 0.9 | 0.1 | ||
| MDA (nmol/l) | Before the intervention | 12.15 ± 3.32 | 18.86 ± 15.97 | 0.12 |
| Two weeks after the intervention | 8.01 ± 2.95 | 18.07 ± 13.83 | 0.01● | |
| P value | 0.01* | 0.8 | ||
| Glutathione (GSH) (µmol/l) | Before the intervention | 16.06 ± 8.19 | 14.34 ± 9.4 | 0.59 |
| Two weeks after the intervention | 17.05 ± 4.59 | 19.73 ± 7.77 | 0.26 | |
| P value | 0.5 | 0.09 |
Notes: Values are Mean ±SD. *P < 0.05 in paired-sample t-test vs baseline. ●P < 0.05 in independent-sample t-test between two groups
The Comparison of Matrix Metalloproteinase, Inflammatory and Oxidant Parameters Before and After Exhaustive Exercise in Both Groups
| Variables | Measurement Stage | Supplement Group | Control Group | P value |
|---|---|---|---|---|
| MMP2 (ng/mL) | Before exhaustive exercise | 35.46 ± 7.79 | 32.6 ±6.76 | 0.29 |
| After exhaustive exercise | 36.49 ± 7.75 | 35.03 ± 8.22 | 0.62 | |
| P value | 0.16 | 0.9 | ||
| MMP9 (ng/mL) | Before exhaustive exercise | 981.85 ± 288. 11 | 988.36 ± 417.34 | 0.96 |
| After exhaustive exercise | 913.58 ± 202.46 | 908.96 ± 412.06 | 0.97 | |
| P value | 0.9 | 0.7 | ||
| TAC (mmol/l) | Before exhaustive exercise | 0.23 ± 0.02 | 0.22 ± 0.02 | 0.83 |
| After exhaustive exercise | 0.24 ± 0.02 | 0.22 ± 0.01 | 0.01● | |
| P value | 0.01* | 0.34 | ||
| hs-CRP (mg/l) | Before exhaustive exercise | 1.1 ± 0.71 | 1.92 ± 1.83 | 0.03● |
| After exhaustive exercise | 1.88 ± 0.8 | 2.5 ± 0.66 | 0.02● | |
| P value | 0.03* | 0.02* | ||
| MDA (nmol/l) | Before exhaustive exercise | 8.01 ± 2.95 | 18.07 ± 13.83 | 0.01● |
| After exhaustive exercise | 19.32 ± 8.49 | 30.5 ± 19.06 | 0.04● | |
| P value | 0.02* | 0.09 | ||
| Glutathione (GSH) (µmol/l) | Before exhaustive exercise3 | 17.05 ± 4.59 | 19.73 ± 7.77 | 0.26 |
| After exhaustive exercise | 23.04 ± 8.93 | 14.42 ± 4.37 | 0.002● | |
| P value | 0.09 | 0.02* |
Notes: Values are Mean ±SD. *P< 0.05 in paired-sample t-test vs before exhaustive exercise. ●P < 0.05 in independent-sample t-test between two groups